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Abstract The ability of anthocyanins to permeate the gastric
mucosa can be suggested as a possible explanation of the fast
kinetics of plasma appearance of anthocyanins in rats and hu-
mans. This paper presents an in vivo experiment aimed to prove
the involvement of the stomach in the absorption of grape an-
thocyanins in rats. The required analytical selectivity and sensi-
tivity was achieved by high-performance liquid chromatography,
diode array detection and mass spectrometry. Malvidin 3-gluco-
side appeared in both portal and systemic plasma after only
6 min. The average concentrations measured in portal and sys-
temic plasma were 0.650# 0.162 WM and 0.234# 0.083 WM
(mean#S.E.M.), respectively.
, 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Anthocyanins are plant secondary metabolites providing
pigmentation to £owers, fruits, seeds and leaves [1]. They
are particularly abundant in red berries and fruits as well as
in red wines; thus their presence in the diet can be notewor-
thy, estimated to be about 0.2 g/day [2]. They are phenolic
compounds, belonging to the vast class of £avonoids, and
occur mainly as glycosides. Because of their phenolic structure
they are e⁄cient antioxidants [3] and are likely to protect cells
against oxygen radical-related damage at the basis of various
pathologies, such as, for instance, atherosclerosis [4], some
cancers [5], diabetes [6]. Thus, the concept evolves that the
human health condition could be partly controlled through
the dietary intake of plant polyphenols [7]. It therefore be-
comes urgent to improve our knowledge of polyphenol avail-
ability from the diet.
Numerous independent studies have reported on the detec-
tion of anthocyanin glycosides in the blood after oral con-
sumption [8^15]. Anthocyanin glycosides are both bulky and
polar compounds and, therefore, carrier-mediated mecha-
nisms of absorption from the gastro-intestinal tract are likely
to be involved.
Bilitranslocase is a plasma membrane organic anion carrier
(TC #2.A.65.1.1, http://tcdb.ucsd.edu/tcdb/background.php)
expressed both in the basolateral domain of the liver plasma
membrane [16] and in the gastric epithelium [17]. It is inhib-
ited competitively by a number of anthocyanins, including
both the mono- and di-glycosylated derivatives, with apparent
inhibition constants in the low-WM range, leading to the hy-
pothesis that it could be involved in the bioavailability of
anthocyanins [18], particularly in the absorption at the gastric
level.
A prerequisite to postulate this role for bilitranslocase in
the stomach is to verify the possibility that absorption of
anthocyanins can indeed take place at this level. This paper
reports on data obtained from in vivo experiments in rats that
con¢rm this hypothesis.
2. Materials and methods
2.1. Standardised mixture of grape anthocyanins
A standardised mixture containing 15 anthocyanins was isolated
from Vitis vinifera (cv. Cabernet Sauvignon) grape with the procedure
described in [18]. It had the following composition, measured as per-
centage HPLC (high-performance liquid chromatography) area at 520
nm: delphinidin 3-glucoside 11.89%; cyanidin 3-glucoside 1.94%; pe-
tunidin 3-glucoside 13.83%; peonidin 3-glucoside 9.26%; malvidin 3-
glucoside 47.18%; delphinidin 3-(6-O-acetyl)-glucoside 2.15%; cyani-
din 3-(6-O-acetyl)-glucoside 0.24%; petunidin 3-(6-O-acetyl)-glucoside
2.21%; peonidin 3-(6-O-acetyl)-glucoside 1.24%; malvidin 3-(6-O-
acetyl)-glucoside 7.49%; delphinidin 3-(6-O-p-coumaroyl)-glucoside
0.12%; cyanidin 3-(6-O-p-coumaroyl)-glucoside 0.03%; petunidin 3-
(6-O-p-coumaroyl)-glucoside 0.40%; peonidin 3-(6-O-p-coumaroyl)-
glucoside 0.17%; malvidin 3-(6-O-p-coumaroyl)-glucoside 1.86%.
2.2. In vivo gastric absorption
The method employed for the study of the in vivo gastric absorp-
tion was that suggested by [19]. It was compliant with rules on animal
experimentation at the University of Trieste. This method employed
anaesthetised rats, thus allowing us to open their abdominal cavity, to
reach their stomach, to ¢ll it with an anthocyanin solution and, after
time intervals, to sample blood from both the portal vein and the
heart. Under the conditions of deep anaesthesia that lasted for the
whole experiment, body temperature, blood £ow and gastro-intestinal
motility are obviously decreased with respect to the untreated animal
and could a¡ect the rate of absorption of test compounds from the
stomach to an extent whose determination fell beyond the scope of
this work. Male, Wistar rats (250 g), fasted for 24 h, were anaesthe-
tised by intra-peritoneal injection of 2.5 ml of a 2.5% (wt/v) solution
of 2,2,2-tribromoethanol (Sigma-Aldrich, Steinheim, Germany) in
ethanol:0.15 M NaCl (1:9 v/v). Induction occurred within a few min-
utes; if required, one additional aliquot of 0.5 ml was administered
intra-muscularly. The abdominal wall was opened longitudinally and
the stomach was located. A ligature was tightened around the cardias,
in order to prevent re£ux into the duodenum. A plastic tubing (outer
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diameter 4 mm) was introduced into the duodenum through an open-
ing and gently forced through the pylorus into the stomach cavity. To
ensure tightness of the system and to avoid blood re£ux into the
stomach, two ligatures were fastened upstream and downstream of
the pyloric sphincter. The tube was connected to a syringe to intro-
duce various solutions into the gastric lumen. This was washed re-
peatedly with 4 ml aliquots of an acidi¢ed saline solution (10 mM
HCl/0.15 M NaCl) until the e¥uent was clear. The stomach was
¢nally ¢lled with the standardised grape anthocyanin mixture (2
mg=3.8 Wmol in 4 ml 10 mM HCl/0.15 M NaCl). In order to obtain
an even distribution of the test compounds inside the organ, the so-
lution was introduced and withdrawn repeatedly and regularly by
means of a syringe. At the end of the incubation times (6, 12, 24
and 36 min), 0.1 ml (500 IU) sodium heparin (Clarisco; Schwarz
Pharma, Milan, Italy) was injected into the inferior cava vein. Imme-
diately thereafter, 1 ml blood was sampled from the portal vein. Then,
the thorax was opened and 3^4 ml systemic blood was obtained by
cardiac puncture. The rat died in less than 1 min.
2.3. Sample preparation
2.3.1. Step 0: preparation of plasma extracts. Blood samples were
put in ice and centrifuged for 1 min at 12 000Ug. The supernatant
consisting of plasma was added to 15 ml plastic tubes containing 4.5
ml (for portal blood samples) or 13.5 ml (for general blood samples)
of methanol (HPLC grade; Carlo Erba, Milan, Italy) saturated with
nitrogen and kept at 320‡C. The tubes were screw-capped, £ushed
with nitrogen again, vortexed and centrifuged at 3640Ug for 10 min
at 4‡C. Supernatants were decanted in glass tubes under a stream of
nitrogen and screw-capped.
2.3.2. Step 1: storage of plasma extracts. Plasma extracts were
stored at 320‡C until sent to the analytical laboratory for further
steps.
2.3.3. Step 2: clean-up of plasma extracts. Methanol was removed
from the sample under reduced pressure on a rotavapor (Bu«chi, Ger-
many) at 38‡C to about the initial volume of the plasma (one-tenth).
The sample was immediately re-diluted in 10 ml 5 mM H2SO4. The
SPE cartridge (Sep Pak C18, 0.35 g; Waters, Milford, MA, USA) was
previously conditioned with 3 ml methanol followed by 5 ml 5 mM
H2SO4, and then the sample was quantitatively loaded. The cartridge
was then washed with 5 ml 5 mM H2SO4: Before elution the cartridge
was dried with nitrogen in order to remove the remaining traces of
water. Anthocyanins were eluted with 4 ml of methanol. The meth-
anol fraction was evaporated to dryness under reduced pressure, at
38‡C. The residue was immediately redissolved in 0.5 ml of a mixture
suitable for HPLC analysis (50% methanol, 50% of 5% formic acid
(HPLC grade; Carlo Erba) in H2O). The sample was ¢ltered through
a 0.22 Wm polyvinylidene di£uoride ¢lter (Millipore, Bedford, MA,
USA) into a HPLC vial, and then analysed by HPLC. A scheme
summarising the steps of cyanidin 3-glucoside extraction from plasma
and the relative recoveries is given in Fig. 1.
2.4. HPLC analysis
Analyses were carried out on a Waters 2690 HPLC system
equipped with Waters 996 diode array detector (DAD) (Waters), Mi-
cromass ZQ electrospray ionisation-mass spectrometry (ESI-MS) sys-
tem (Micromass, Manchester, UK), and MassLynx Software version
3.5 (Micromass). Separation was performed using a column ODS
Hypersil 200U2.1 mm (5 Wm) with guard ODS Hypersil 20U2.1
mm (5 Wm) (Agilent, Palo Alto, CA, USA). The mobile phases con-
sisted of 5% formic acid in H2O (A) and 5% formic acid in methanol
(B). Separation was carried out at 40‡C in 30 min, under the following
conditions: linear gradients starting at 16% B, to 36% B in 10 min, to
45.2% B in 7 min, to 51.2% B in 4 min, to 64% B in 5 min, to 90% B
in 4 min. The column was equilibrated for 4 min prior to each anal-
ysis. The £ow rate was 0.4 ml/min and the injection volume 40 Wl. The
UV^VIS (visible) spectra were recorded from 230 to 600 nm, with
detection at 520 nm. The MS detector operated at a capillary voltage
of 3000 V, an extractor voltage of 6 V, a source temperature of 105‡C,
a desolvation temperature of 200‡C, a cone gas £ow (N2) of 30 l/h, a
desolvation gas £ow (N2) of 450 l/h. The outlet of the HPLC system
was split (9:1) to the ESI interface of the mass analyser. ESI-mass
spectra ranging from m/z 200 to 700 were taken in positive mode with
a dwell time of 0.1 s. The cone voltage was set in scan mode at the
value of 65 V for the identi¢cation based on the aglycon peak, and at
30 V for the identi¢cation based on both the fragment aglycon and
molecular ion. The following single ions (m/z) were monitored for the
quanti¢cation: 287.2 (50 V) for cyanidin derivatives, 301.2 (50 V) for
peonidin derivatives, 303.2 (50 V) for petunidin derivatives, 317.2
(50 V) for delphinidin derivatives and 331.3 (65 V) for malvidin de-
rivatives. The calibration curves for standard malvidin 3-glucoside,
petunidin 3-glucoside, delphinidin 3-glucoside, peonidin 3-glucoside
and cyanidin 3-glucoside were linear in the range 140^4800 nM,
with coe⁄cient of correlation v 0.9983 for MS detection and
v 0.9995 for VIS detection. Samples were quanti¢ed by single ion
monitoring in MS, with the external standard method. An example
of the chromatograms of the anthocyanins identi¢ed in a sample of
rat portal plasma is given in Fig. 2.
3. Results and discussion
3.1. Method validation
To unambiguously detect trace levels of anthocyanins in
plasma, a HPLC method with double detection, consisting
of ESI-MS and DAD detection, was developed. The single
ion monitoring by MS was the ¢rst choice for the quanti¢ca-
tion, being both more sensitive and more selective than the
DAD detection at 520 nm. The limit of detection (LOD) of
the ¢ve anthocyanins was in the range 19^54 nM (Table 1)
with signal-to-noise ratio (S/N) v 3. The limit of quanti¢ca-
tion (S/Nv 10) was in the range 63^182 nM. This sensitivity
was considered adequate for detecting anthocyanins in plas-
ma, also taking into account that sample preparation resulted
in ca 0.8-fold and three-fold concentration of portal and sys-
temic plasma samples, respectively. The MS signal in scan
mode allowed us to con¢rm the identity of the peaks by com-
paring their spectra with those of pure standards. The DAD
signal provided a second way for the quanti¢cation of the
peaks above the limit of quanti¢cation (LOQ) (Table 1),
and gave additional information on the identity of the com-
pounds, by comparing their UV^VIS spectra with that of pure
compounds.
The distribution of the test results under repeatability con-
ditions [20] was estimated for the retention times and for the
determination of the concentration of the main anthocyanins
in a diluted stock solution (N=11, Table 1). The coe⁄cient of
variation (CV) for the retention times was in the range 0.20^
0.50% for MS signal, and 0.22^0.30% for DAD, while the CV
Table 1
Instrumental LOD, LOQ and repeatability for MS single ion monitoring and DAD of anthocyanins
Anthocyanin Detection by MS, single ion Diode array detection, 520 nm
LOD (nM) LOQ (nM) Repeatabilitya (CV, %) LOD (nM) LOQ (nM) Repeatabilitya (CV, %)
Malvidin 3-glucoside 28.74 95.69 8.90 62.03 206.70 5.94
Petunidin 3-glucoside 54.59 181.63 11.76 71.29 237.58 3.38
Delphinidin 3-glucoside 52.92 176.74 11.34 54.52 181.53 2.87
Peonidin 3-glucoside 18.85 62.95 8.51 48.32 161.00 2.94
Cyanidin 3-glucoside 25.37 84.79 11.76 57.14 190.62 3.23
aStandard solution containing 300 ng/ml of each compound, N=11.
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of the concentration ranged between 8.51% and 11.76% for
MS, and between 2.87% and 5.94% for DAD detection.
The experimental recoveries of cyanidin 3-glucoside, malvi-
din 3-glucoside, peonidin 3-glucoside, petunidin 3-glucoside
and malvidin 3-glucoside acetic ester from blood spiked with
the pure anthocyanin mixture were, respectively, 57.6%
(CV=20,8%), 41.9% (CV=19.7%), 42.6% (CV=17.6%),
54.4% (CV=17.8%), 48.4% (CV=19.5%) (N=9). Cyanidin
3-glucoside was used in further tests aimed to assess both
the stability during storage and the e⁄ciency of extraction
from plasma. The results of these tests are summarised in
Fig. 1. Diluted stock solutions of cyanidin 3-glucoside in
methanol or in 0.5% acetic acid in methanol were proved to
be stable up to 7 days at 320‡C, +4‡C and room temperature
(ca 20‡C) (step 1, Fig. 1). Methanol was preferred for the
storage of diluted plasma samples, since the acid solution is
known to exert hydrolytic activity on the acetic esters of an-
thocyanins [21]. The recovery of cyanidin 3-glucoside from a
methanolic solution during the sample clean-up by C18 car-
tridge (N=4) was complete (98.69%), and repeatable (CV=
3.87%). The experimental recovery from rat plasma (steps
1+2), spiked with cyanidin 3-glucoside, was estimated to be
89.51% with CV=4.76% (N=6). In conclusion, these data
show that a substantial fraction (about 50%) of the mixture
components was associated with red blood cells and that the
recovery from plasma was quite satisfactory.
3.2. Absorption of anthocyanins from the stomach
To test whether the stomach is a site of absorption of an-
thocyanins, a surgical procedure was implemented on anaes-
thetised rats [19], allowing us to introduce solutions of an
anthocyanin mixture isolated from V. vinifera (cv. Cabernet
Sauvignon, Fig. 2A) grape into the stomach, ligated at both
the cardias and the pylorus levels. Rats were grouped accord-
ing to the duration of the absorption experiment and blood
samples were ultimately taken from both their portal vein and
their heart. Analysis of anthocyanins in plasma (Fig. 2B) re-
vealed that of all components of the mixture, malvidin 3-glu-
coside was detected at the highest concentration, which was
expected from its being the most abundant single anthocyanin
in the standardised grape extract. Some chromatograms also
revealed the presence of peonidin 3-glucoside, petunidin 3-
glucoside and minute amounts of the malvidin 3-glucoside
acetic ester (Fig. 2B). Interestingly, neither anthocyanin agly-
1. Storage of plasma extracts 
2. Clean-up of plasma extracts 
(89,51%) (100,00%) 
Fig. 1. Flow sheet of the sample preparation steps with indication
of the recovery in parentheses.
Fig. 2. HPLC-DAD-MS analysis of anthocyanin standard mixture
(A) and a sample of rat portal plasma (B). The diode array signal
at 520 nm (upper trace) and the MS single ion signals (lower traces)
at m/z 287.2, 301.2, 303.2, 317.2 and 331.3 are shown. The vertical
axis is normalised. 1= delphinidin 3-glucoside; 2 = cyanidin 3-gluco-
side; 3= petunidin 3-glucoside; 4 = peonidin 3-glucoside; 5 =malvi-
din 3-glucoside; 6= delphinidin-3-(6-O-acetyl)-glucoside; 7= cyanidin
3-(6-O-acetyl)-glucoside, 8= petunidin 3-(6-O-acetyl)-glucoside,
9= peonidin 3-(6-O-acetyl)-glucoside, 10=malvidin 3-(6-O-acetyl)-
glucoside, 11=malvidin 3-(6-O-coumaroyl)-glucoside.
Table 2
Malvidin 3-monoglucoside concentration in plasma sampled from either the portal vein or the heart
[Malvidin 3-glucoside] in plasma (WM)
Time (min) Portal plasma Systemic plasma
Means N Std error Min Max Means N Std error Min Max
6 0.789 5 0.491 0.043 2.554 0.098 5 0.078 0.009 0.410
12 0.468 5 0.228 0.062 1.203 0.300 5 0.239 0.013 1.254
24 0.470 4 0.285 0.021 1.303 0.307 4 0.273 0.006 1.126
36 0.838 5 0.275 0.157 1.341 0.263 6 0.103 0.023 0.664
All groups 0.650 19 0.162 0.021 2.554 0.234 20 0.083 0.006 1.254
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cones nor conjugated derivatives could be detected in the
blood extracts. Table 2 shows malvidin 3-glucoside concentra-
tion in either portal or systemic plasma from rats that received
the anthocyanin mixture for the times indicated. High animal
variability accounted for the relatively large values of stan-
dard errors, presumably due in large part to the deep anaes-
thesia, a¡ecting di¡erently animals already worn out by 24 h
fasting.
Malvidin 3-glucoside appeared in both portal and systemic
plasma after only 6 min, and by this time an apparent steady
state was reached. This can be estimated by averaging all the
data of either the portal or the systemic plasma samples. The
values are 0.650V 0.162 and 0.234V 0.083 WM (meanV
S.E.M.), respectively. The concentrations found in the portal
blood are always higher than those in the systemic circulation,
obviously due to the proximity of the portal blood district to
the site of absorption. The lower concentration values of the
systemic plasma may re£ect: (a) speci¢c hepatic uptake, (b)
dilution into a larger vascular compartment, and (c) distribu-
tion in peripheral tissues. The data in systemic plasma are of
the same order of magnitude as those reported in studies with
human subjects receiving comparable amounts/kg body
weight [8,9], con¢rming that anthocyanin bioavailability in
mammals is limited [22]. Nevertheless, malvidin 3-monogluco-
side concentrations in systemic plasma are still in a range
compatible with e¡ective antioxidant activity [23] and, in ad-
dition, the concentrations found in the portal blood are close
to the half-saturation of bilitranslocase [18], which could thus
play a relevant role in facilitating their uptake into the liver,
where they have been shown to protect against oxidative
stress [24].
The ability of anthocyanins to permeate the gastric mucosa,
and possibly through a bilitranslocase-mediated mechanism,
could be at the basis of the fast kinetics of plasma appearance
of anthocyanins in rats [15], as well as in humans [9,10,12].
Although absorption is likely to occur also in the upper in-
testine, the data presented above raise the question of the
relative contribution of the stomach in the process of absorp-
tion of anthocyanins, whose fate in lower segments of the
digestive tract is complicated by degradation, dependent on
both pH and microbial metabolism.
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